NAVIDEA BIOPHARMACEUTICALS I's ticker is NAVB and the CUSIP is 63937X202. A total of 26 filers reported holding NAVIDEA BIOPHARMACEUTICALS I in Q1 2022. The put-call ratio across all filers is 0.68 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $26,634 | +23.8% | 102,440 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $21,512 | -17.3% | 102,440 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $26,000 | -64.9% | 102,440 | 0.0% | 0.00% | -50.0% |
| Q2 2022 | $74,000 | -8.6% | 102,440 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $81,000 | -20.6% | 102,440 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $102,000 | -43.0% | 102,440 | 0.0% | 0.00% | -33.3% |
| Q3 2021 | $179,000 | -4.3% | 102,440 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $187,000 | -54.3% | 102,440 | -49.4% | 0.00% | -62.5% |
| Q1 2021 | $409,000 | +73.3% | 202,440 | +84.1% | 0.01% | +60.0% |
| Q4 2020 | $236,000 | -34.1% | 109,940 | -17.1% | 0.01% | -37.5% |
| Q3 2020 | $358,000 | +45.5% | 132,540 | +111.9% | 0.01% | +60.0% |
| Q2 2020 | $246,000 | – | 62,540 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Allred Capital Management, LLC | 52,926 | $113,000 | 0.06% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 109,940 | $236,000 | 0.01% |
| PATHSTONE FAMILY OFFICE, LLC | 10,050 | $22,000 | 0.00% |
| Sowell Financial Services LLC | 11,190 | $24,000 | 0.00% |
| TWO SIGMA INVESTMENTS, LP | 101,949 | $219,000 | 0.00% |
| SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC | 32,822 | $71,000 | 0.00% |
| UBS Group AG | 816 | $2,000 | 0.00% |
| IFP Advisors, Inc | 50 | $0 | 0.00% |
| OSAIC HOLDINGS, INC. | 6 | $0 | 0.00% |
| Jacobi Capital Management LLC | 1,000 | $2,000 | 0.00% |